Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression

Experimental and Therapeutic Medicine

Volumn 10, Issue 5, 2015, Pages 1829-1834

  Lu, Xiaodong ^a,b   Chen, Lufang ^a   Chen, Yuanyuan ^a   Shao, Qixiang ^a   Qin, Wenxin ^b  

^a JIANGSU UNIVERSITY   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Apoptosis; Bafilomycin A1; BEL 7402; HO 8910; MicroRNA; Vacuolar H^{+< sup> ATPase}

Indexed keywords

BAFILOMYCIN A1; CASPASE 3; CASPASE 9; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 1246; MICRORNA 149; MICRORNA 181A; MICRORNA 210; MICRORNA 339; MICRORNA 638; MICRORNA 923; MICRORNA 99A; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BEL 7402 CELL LINE; CANCER GROWTH; CELL INVASION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE ONTOLOGY; HO 8910 CELL LINE; HUMAN; HUMAN CELL; INFORMATION PROCESSING; LIPID METABOLISM; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; LIVER METASTASIS; LYSOSOME; MICROARRAY ANALYSIS; OVARIAN CANCER CELL LINE; OVARY CANCER; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOFT AGAR COLONY FORMATION ASSAY; TRANSMISSION ELECTRON MICROSCOPY; WST ASSAY;

EID: 84942246495     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2758     Document Type: Article

References (28)

1. Nishi T and Forgac M: The vacuolar (H+)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 3: 94-103, 2002.
2. Marshansky V, Rubinstein JL and Grüber G: Eukaryotic V-ATPase: Novel structural findings and functional insights. Biochimica Biophy Acta 1837: 857-879, 2014.
3. Breton S and Brown D: Regulation of luminal acidification by the V-ATPase. Physiology (Bethesda) 28: 318-329, 2013.
4. Sun-Wada GH and Wada Y: Vacuolar-type proton pump ATPases: Acidification and pathological relationships. Histol Histopathol 28: 805-815, 2013.
5. Barar J and Omidi Y: Dysregulated pH in tumor microenvironment checkmates cancer therapy. BioImpacts 3: 149-162, 2013.
6. Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE and Gorelick F: The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest 91: 732-743, 2011.
7. Sennoune SR and Martinez-Zaguilan R: Vacuolar H(+)-ATPase signaling pathway in cancer. Curr Protein Pept Sci 13: 152-163, 2012.
8. Fogarty FM, O'Keeffe J, Zhadanov A, Papkovsky D, Ayllon V and O'Connor R: HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H(+) ATPase. Oncogene 33: 4653-4663, 2014.
9. Nakashima S, Hiraku Y, Tada-Oikawa S, Hishita T, Gabazza EC, Tamaki S, Imoto I, Adachi Y and Kawanishi S: Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem 134: 359-364, 2003.
10. Yan Y, Denef N and Schüpbach T: The vacuolar proton pump, V-ATPase, is required for notch signaling and endosomal trafficking in drosophila. Dev Cell 17: 387-402, 2009.
11. Marshansky V and Futai M: The V-type H+-ATPase in vesicular trafficking: Targeting, regulation and function. Curr Opin Cell Biol 20: 415-426, 2008.
12. Lee GH, Kim DS, Kim HT, Lee JW, Chung CH, Ahn T, Lim JM, Kim IK, Chae HJ and Kim HR: Enhanced lysosomal activity is involved in Bax inhibitor-1-induced regulation of the endoplasmic reticulum (ER) stress response and cell death against ER stress: Involvement of vacuolar H+-ATPase (V-ATPase). J Biol Chem 286: 24743-24753, 2011.
13. Avnet S, Di Pompo G, Lemma S, Salerno M, Perut F, Bonuccelli G, Granchi D, Zini N and Baldini N: V-ATPase is a candidate therapeutic target for Ewing sarcoma. Biochim Biophys Acta 1832: 1105-1116, 2013.
14. Hernandez A, Serrano-Bueno G, Perez-Castineira JR and Serrano A: Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer. Curr Pharm Des 18: 1383-1394, 2012.
15. Graham RM, Thompson JW and Webster KA: Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis. Oncotarget 5: 1162-1173, 2014.
16. Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, et al: Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Nat Cancer Inst 96: 1702-1713, 2004.
17. Morimura T, Fujita K, Akita M, Nagashima M and Satomi A: The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma. Pediat Surg Int 24: 1087-1094, 2008.
18. Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 73: 473-477, 2013.
19. Wang Y and Taniguchi T: MicroRNAs and DNA damage response: Implications for cancer therapy. Cell Cycle 12: 32-42, 2013.
20. von Schwarzenberg K, Wiedmann RM, Oak P, Schulz S, Zischka H, Wanner G, Efferth T, Trauner D and Vollmar AM: Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J Biol Chem 288: 1385-1396, 2013.
21. Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nagakawa T, Miwa K, Kurashima K, Numata M, et al: Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol 185: 324-330, 1998.
22. Hendrix A, Sormunen R, Westbroek W, Lambein K, Denys H, Sys G, Braems G, Van den Broecke R, Cocquyt V, Gespach C, et al: Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer 133: 843-854, 2013.
23. Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou CX, Zhang C, Zhang Z and Li X: The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagn Pathol 8: 145, 2013.
24. Dechant R, Binda M, Lee SS, Pelet S, Winderickx J and Peter M: Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J 29: 2515-2526, 2010.
25. Valapala M, Wilson C, Hose S, Bhutto IA, Grebe R, Dong A, Greenbaum S, Gu L, Sengupta S, Cano M, et al: Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy 10: 480-496, 2014.
26. Zhang CS, Jiang B, Li M, Zhu M, Peng Y, Zhang YL, Wu YQ, Li TY, Liang Y, Lu Z, et al: The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab 20: 526-540, 2014.
27. Cao X, Yang Q, Qin J, Zhao S, Li X, Fan J, Chen W, Zhou Y, Mao H and Yu X: V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells. Am J Physiol Renal Physiol 302: F1121-F1132, 2012.
28. Jung JY and Robinson CM: Interleukin-27 inhibits phagosomal acidification by blocking vacuolar ATPases. Cytokine 62: 202-205, 2013.